Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis
Background: The advent of cystic fibrosis transmembrane conductance regulator protein (CFTR) modulators like ivacaftor have revolutionised the treatment of cystic fibrosis (CF). However, due to the plethora of variances in disease manifestations in CF, there are inherent challenges in unified responses under CFTR modul...
Tony Velkov, Gauri G. Rao, Helmut Ellemunter et al.
· UNC Libraries · 0 citations